Ausgabe 2/2011
Inhalt (12 Artikel)
Defining the Safety of Anacetrapib, a CETP Inhibitor, in Patients at High Risk for Coronary Heart Disease: the DEFINE study
Cora Elizabeth Lewis
Fitness, Fatness, and Cardiovascular Disease Risk and Outcomes
John M. Jakicic, Anne E. Mishler, Renee Rogers
Cocoa Consumption, Cocoa Flavonoids, and Effects on Cardiovascular Risk Factors: An Evidence-Based Review
Scott R. Bauer, Eric L. Ding, Liesbeth A. Smit
Obesity, Age, and Cardiac Risk
Surya M. Artham, Carl J. Lavie, Alban De Schutter, Hector O. Ventura, Richard V. Milani
Carotid Intima Media Thickness Versus Carotid Plaque in Cardiovascular Risk Evaluation
Smita Negi, Tyler Murray, Vijay Nambi
Clinical Utility of Multiple Biomarker Panels for Cardiovascular Disease Risk Prediction
Maria Hughes, Frank Kee, Veikko Salomaa
The Rise and Fall of Hypertension: Lessons Learned from Eastern Europe
Agata Bielecka-Dabrowa, Wilbert S. Aronow, Jacek Rysz, Maciej Banach